1 - 10 of 33 articles
This case report describes retinal arterial tortuosity associated with moyamoya disease.
Research Prolonged Monthly Therapy for Diabetic Macular Edema Avery and Gordon expand on analyses evaluating the systemic safety of intravitreous anti–vascular endothelial growth factor injections in patients with diabetic macular edema by investigating a subgroup of these patients with monthly...
This Viewpoint assesses the ethical justification for the use of placebo procedures in ophthalmic surgery trials.
Mission Statement: To be the indispensable source of ophthalmic knowledge by promptly publishing innovative, clinically relevant research through consistent and authoritative peer review and, thereby, to be the first choice of authors for their important manuscripts. Editor: Neil M. Bressler, MD...
ImportanceTo our knowledge, longitudinal assessment of depression, anxiety, and decision regret (a sense of disappointment or dissatisfaction in the decision) in patients undergoing prognostication for uveal melanoma does not exist.
ObjectiveTo report on depression, anxiety, and decision regret...
ImportanceThe Diabetic Retinopathy Clinical Research Network (DRCR Network), sponsored by the National Eye Institute, reported the results of a comparative effectiveness randomized clinical trial (RCT) evaluating the 3 anti–vascular endothelial growth factor (anti-VEGF) agents aflibercept (2.0...
A man in his 40s from India presents with blurred vision, pain, posterior vitreous detachment, macular edema, and extensive peripheral retinal hemorrhage with obliterative vasculitis in the left eye. What would you do next?
This case report describes periorbital necrotizing fasciitis after a patient received a dexamethasone intravitreal implant injection for diabetic macular edema.
ImportanceAnti–vascular endothelial growth factor (VEGF) therapy is commonly used to treat numerous retinal conditions and appears safe, yet controversy remains regarding systemic safety.
ObjectiveTo evaluate the systemic safety of intravitreous anti-VEGF injections in high-risk patients with...
Read and print from thousands of top scholarly journals.
Continue with Facebook
Sign up with Google
Log in with Microsoft
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.